Boroń D, Kotrych D, Bartkowiak-Wieczorek J, Uzar I, Bogacz A, Kamiński A
Department of Histology and Embryology, Medical University of Silesia, SMDZ in Zabrze, Poland.
Department of Orthopaedics, Traumatology and Orthopaedic Oncology, Pomeranian Medical University, Szczecin, Poland.
Int Immunopharmacol. 2015 Sep;28(1):477-86. doi: 10.1016/j.intimp.2015.07.015. Epub 2015 Jul 18.
The aim of the study was to evaluate the frequency of gene polymorphisms OPG -163A/G, -950T/C and 1181G/C, assessing their relations with the clinical parameters of osseous turnover and the degree of postmenopausal osteoporosis.
The study included 800 women of postmenopausal (505) and reproductive (295) age from Poland. The postmenopausal group included women with osteoporosis and osteopenia, as well as healthy individuals. All the women of reproductive age were healthy. The frequency of the tested gene polymorphisms was evaluated within the group where BMD (bone mineral density) was marked and also in the control group.
The frequencies of the polymorphisms of OPG genotypes in the women were characteristic of the population.
OPG -950T/C polymorphism has been associated with body weight and birth weight. OPG 1181G/C and OPG -163A/G polymorphisms have been associated not only with body weight and birth weight, but also with reduced bone density and an increased risk of postmenopausal osteoporosis.
Evaluation of the polymorphism -950T/C of the OPG gene showed that the CC genotype may appear as an increased risk factor for the faster loss of bone mass and the onset of osteoporosis in Polish postmenopausal women. This polymorphism may be a genetic marker that is responsible for the development of osteoporosis. The homozygous genotypes of polymorphisms 1181G/C and -163A/G of the OPG gene may play a role in increased risks of osteoporosis and may be linked to the birth weights of women.
本研究旨在评估骨保护素(OPG)基因多态性-163A/G、-950T/C和1181G/C的频率,评估它们与骨转换临床参数及绝经后骨质疏松程度的关系。
该研究纳入了来自波兰的800名绝经后(505名)和育龄期(295名)女性。绝经后组包括患有骨质疏松症和骨质减少症的女性以及健康个体。所有育龄期女性均健康。在标记了骨密度(BMD)的组以及对照组中评估了所检测基因多态性的频率。
女性中OPG基因型多态性的频率具有人群特征。
OPG -950T/C多态性与体重和出生体重相关。OPG 1181G/C和OPG -163A/G多态性不仅与体重和出生体重相关,还与骨密度降低和绝经后骨质疏松风险增加相关。
对OPG基因-950T/C多态性的评估表明,CC基因型可能是波兰绝经后女性骨量更快丢失和骨质疏松发病风险增加的因素。这种多态性可能是导致骨质疏松症发生的遗传标志物。OPG基因1181G/C和-163A/G多态性的纯合基因型可能在骨质疏松症风险增加中起作用,并且可能与女性的出生体重有关。